Market Research Blog – Page 3749 – New Product Development

Global Thoracolumbar Stabilization Devices Industry Poised for a Remarkable US$ 2 Billion Breakthrough by 2033, Driven by a Steady 5.5% CAGR – Insights by FMI

The Global Thoracolumbar Stabilization Devices Industry is on track for unprecedented growth, with a projected surge to an impressive US$ 2,066.2 million by 2033, up from US$ 1,206.7 million in 2023, according to a recent report by leading industry analysts at FMI. This remarkable expansion represents a compelling Compound Annual Growth Rate (CAGR) of 5.5% over the period from 2023 to 2033.

The escalating demand for thoracolumbar stabilization devices signals a paradigm shift in spinal healthcare, highlighting their growing significance in addressing spinal instability. These devices have gained substantial momentum and are emerging as a formidable alternative to traditional spinal fusion methods.

In contrast to fusion methods that eliminate all movement, thoracolumbar stabilization devices preserve a degree of spine mobility, striking a delicate balance between stability and flexibility. Beyond contributing to straightening the spine’s curve, these devices provide substantial support to the thoracic spine. This transformative advancement in spinal healthcare represents a significant milestone for the industry, aligning with the evolving needs and preferences of patients seeking effective and flexible solutions.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-4001

Global Thoracolumbar Stabilization Devices Industry: Drivers and Restraints

The rising occurrence of spine injuries and fractures is likely to increase the market for Thoracolumbar Stabilisation Devices. The growing demand for non-invasive surgical techniques is also projected to propel the Thoracolumbar Stabilisation Devices market forward. The rising prevalence of spine abnormalities among the elderly is also likely to drive the market for Thoracolumbar Stabilisation Devices.

The high initial cost of these devices may limit the market expansion of Thoracolumbar Stabilisation Devices.

Global Thoracolumbar Stabilization Devices Industry: Overview

The market for Thoracolumbar Stabilisation Devices is predicted to expand significantly throughout the forecast period. Spinal injury and chronic back pain are among the most common disorders, and their increasing prevalence is likely to fuel the growth of the Global Thoracolumbar Stabilization Devices Industry.

Titanium gadgets are predicted to be the greatest revenue-generating market due to their lightweight and active character. Because all surgical stabilization of the thoracolumbar region begins with the posterior implant, posterior Thoracolumbar Stabilisation Devices are expected to generate more revenue than anterior devices.

The market for Thoracolumbar Stabilisation Devices is predicted to increase steadily due to cost-effectiveness and better disease management when compared to analgesics. These devices are available in several shapes and sizes, allowing users to select from a wide range of alternatives, which is likely to boost the revenue of the Thoracolumbar Stabilisation Devices market.

Unveiling the key assumptions of the study. ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-4001

Thoracolumbar Stabilization Devices Industry: Region-Wise Outlook

Geographically, the Global Thoracolumbar Stabilization Devices Industry can be segmented into the regions: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and the Middle East & Africa. North America is the biggest and most attractive market for thoracolumbar stabilization devices due to the presence of major players, awareness among people, better healthcare infrastructure, and reimbursement policies.

Followed by which is Europe. Asia Pacific region is expected to be fastest fastest-growing Global Thoracolumbar Stabilization Devices Industry due to the large patient pool, increasing healthcare infrastructure, and awareness among people.

Global Thoracolumbar Stabilization Devices Industry: Key Players

Some of the market participants in the Global Thoracolumbar Stabilization Devices Industry are, B. Braun Melsungen AG, Zimmer, Inc., Coligne AG, Yellowsteps SAS, Medyssey Co. Ltd., DePuy Synthes Company, Aesculap Implant Systems, LLC, Ulrich Medical, Medtronic Public Limited Company and Stryker. Companies are focusing on the advancement of devices and the development of minimally invasive screws and roads.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, applications, and grades.

Click Here To Buy Your Full Report
https://www.futuremarketinsights.com/checkout/4001

Key Segments Profiled in the Global Thoracolumbar Stabilization Devices Industry Survey

By Device Type:

Anterior Stabilization Device
Posterior Stabilization Device
Retractors

By Material:

Titanium
Stainless Steel

By End Use:

Hospitals
Clinics
Ambulatory Surgical Centers

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Robotic Biopsy Devices Industry Achieves US$ 1,072.3 Million, Riding High on 9.3% CAGR Momentum | FMI

In a groundbreaking achievement, the Global Robotic Biopsy Devices Industry has attained an unprecedented valuation of US$ 440.2 million in 2023, as reported by a recent study. The industry is poised for continued success, with projections indicating a robust Compound Annual Growth Rate (CAGR) of 9.3% throughout the forecast period.

The remarkable growth of the robotic biopsy devices industry can be attributed to the relentless pursuit of innovation and cutting-edge advancements in robotic biopsy systems. In 2023, these systems held a commanding 59.8% market share, solidifying their position as a game-changer in the global market. The incorporation of state-of-the-art robotic systems has significantly raised the bar for neurosurgical procedures, delivering unrivaled precision and improved patient outcomes.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-15412

The market for Robotic Biopsy Devices is anticipated to grow at a fast pace over the projected years due to the rising need for safe and effective minimally invasive procedures and the growing use of automated systems in the healthcare sector. It can be further attributed to the rapid transformation of conventional healthcare systems to integrated digital technology.

Key Takeaways: Global Robotic Biopsy Devices Industry

By product, the systems segment is expected to showcase high growth at a CAGR of 4% by the end of 2032.
By application, the brain biopsy category is leading the Global Robotic Biopsy Devices Industry and is projected to exhibit a CAGR of 3% during the forecast period.
By end user, hospitals held around 5% of the Global Robotic Biopsy Devices Industry share in 2021.
The U.S. currently dominates the North America Robotic Biopsy Devices market and it generated a share of about 8% in 2021.
The U.K. is set to hold a share of nearly 2% in the Global Robotic Biopsy Devices Industry during the assessment period.

“Increasing use of automated technologies for surgical procedures and growing global burden of chronic diseases are expected to drive sales of Robotic Biopsy Devices,” says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)

Reach Out to Our Analyst For Your Queries
https://www.futuremarketinsights.com/ask-question/rep-gb-15412

Competition Landscape: Global Robotic Biopsy Devices Industry

The market for Robotic Biopsy Devices is oligopolistic, with the presence of a few established manufacturers. The product range of every player in the market varies as per the competitors’ licensed novel devices with unique applications. Key players are striving to gain regulatory authorizations for creating new medical devices, generating high product sales, and initiating marketing purposes.

In October 2021, Medtronic reported that the Hugo robotic-assisted surgery (RAS) system had been granted the CE (Conformité Européenne) Mark, allowing for sales of the system across Europe.

Key Players

Medtronic
Renishaw plc
iSYS Medizintechnik GmbH
Mazor Robotics
Biobot Surgical Pte Ltd
Medrobotics
Medtech SA

What Does the Global Robotic Biopsy Devices Industry Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the Global Robotic Biopsy Devices Industry in its latest study, presenting a historical demand assessment of 2012 to 2021 and projections for 2022 to 2032.

Click Here To Buy Your Full Report
https://www.futuremarketinsights.com/checkout/15412

Global Robotic Biopsy Devices Industry Outlook by Category

By Product:

Systems
Instrument & Accessories

By Application:

Brain Biopsy
Lung Biopsy
Prostate biopsy
Others

By End User:

Hospitals
Ambulatory Surgical Centers
Academic & Research Institutes

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Global Veterinary Orthotics-Prosthetics Industry to Surge at 9.5% CAGR, Reaching US$ 164.2 Million by 2033 | FMI

In its latest report, Future Market Insights (FMI) offers a promising outlook for the Global Veterinary Orthotics-Prosthetics Industry, with a projected valuation of over US$ 66.5 million in 2023 and a robust compound annual growth rate (CAGR) of 9.5% throughout the forecast period. This remarkable growth is attributed to the increasing demand for veterinary orthotic prosthetics devices, which are playing a pivotal role in the rehabilitation process for injured animals.

According to FMI’s report, the primary driver of this surge in demand is the growing number of cases involving injured animals. Veterinary orthotic prosthetics devices provide essential support, alignment, immobilization, muscle reinforcement, and enhanced functionality for animals facing physical challenges. As a result, they have become indispensable in the treatment and recovery of animals, particularly in the wake of injuries or illnesses that affect their mobility and overall well-being.

The market study depicts an extensive analysis of all the players running in the Global Veterinary Orthotics-Prosthetics Industry report based on distribution channels, local networks, innovative launches, industrial penetration, production methods, and revenue generation. Further, the market strategies and mergers & acquisitions associated with the players are enclosed in the Global Veterinary Orthotics-Prosthetics Industry report.

In its latest business report, Future Market Insights elaborates on the current situation of the Global Veterinary Orthotics-Prosthetics Industry in terms of volume, value, production, and consumption. The report scrutinizes the market into various segments, end uses, regions, and players based on demand patterns, and future prospects.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-4512

Canine Rehabilitation’s Role in Shaping the Global Veterinary Orthotics-Prosthetics Industry”

The Global Veterinary Orthotics-Prosthetics Industry is on an upward trajectory, largely fueled by the increasing awareness of rehabilitation options for animals. Canine rehabilitation, in particular, has witnessed significant advancements in contemporary veterinary medicine, driven by ongoing research initiatives from various institutions, thereby amplifying the demand for veterinary orthotics and prosthetics.

The market is further poised for growth, spurred by continuous innovations in prosthetic device technology, the trend towards customized prosthetic solutions, and the global consolidation of the Global Veterinary Orthotics-Prosthetics Industry.

Key Challenges for the Orthotics-Prosthetics Market:

Limited Government and Non-Profit Support: A notable impediment to the Global Veterinary Orthotics-Prosthetics Industry’s growth is the lack of substantial support from government and non-profit organizations.

Awareness Gap: The market is hindered by a deficiency in awareness regarding the availability and benefits of veterinary orthotics-prosthetics.

Professional Expertise Shortage: Inappropriate use of these devices is another constraint, stemming from the scarcity of skilled professionals, which may restrict the sales of veterinary orthotics and prosthetics.

What key insights does the Global Veterinary Orthotics-Prosthetics Industry research provide?

Historical and current year revenue of related Veterinary Orthotics-Prosthetics market players analyzed at the regional level.
One by one company profile of prominent stakeholders.
Analysis of the Veterinary Orthotics-Prosthetics market size based on product type and end-use type.
Accurate Veterinary Orthotics-Prosthetics market forecast in terms of value and volume in numbers and percentages.
Demand prospect of each segment covered in the report.

Discovering the assumptions behind the study. Get Expert Advice.
https://www.futuremarketinsights.com/ask-question/rep-gb-4512

Key Companies Profiled:

OrthoPets LLC.
Animal Ortho Care
AAA Orthotics and Prosthetics
Anchor Orthotics & Prosthetics
Animal Care Castle Rock OrthoPets Castle Rock
Appletree Orthotic Services Ltd
Animal Orthocare
Avondale Veterinary Healthcare Complex OrthoPets Iowa
Buddy Braces
Dogs in Motion Canine Rehabilitation OrthoPets Australia
Equisport Medicine OrthoPets Washington
com
Hanger Clinic
Holistic vet OrthoPets South Africa
G. McGinness Prosthetics & Orthotics
K-9 Orthotics & Prosthetics

Key Segments

By Product Type:

Braces
Stifle braces
Carpal/Tarsal braces
Hip braces
Contracture Bracing
Deformity Braces
Prosthetics
Others

Get Your Customized Impactful Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-4512

By End User:

Veterinary Hospitals
Prosthetics clinics
Rehabilitation Center
Others

By Region:

North America
Europe
Asia-Pacific
Latin America
MEA

The Global Veterinary Orthotics-Prosthetics Industry research gets rid of the following queries:

How the market for Veterinary Orthotics-Prostheticss is expected to shape in the coming ten years?
What strategies are the Veterinary Orthotics-Prosthetics market vendors implementing to stay ahead of their rivals?
Why are consumers shifting towards alternative Veterinary Orthotics-Prosthetics products?
What innovative technologies are the Veterinary Orthotics-Prosthetics players using to get an edge over their rivals?
What are the restraints affecting the growth of the Global Veterinary Orthotics-Prosthetics Industry?

Why choose Future Market Insights?

Modern technologies, such as artificial intelligence, to provide updated industry trends.
Data collection from implementation vendors, service providers, and raw material suppliers to provide a clear perspective.
Interaction with research scientists and development heads to understand the nature of the market more precisely.
Three-step quality check process – Data collection, triangulation, and validation.
24/7 availability of services.

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Global Stabilometric Platform Industry Set to Skyrocket, Anticipated to Reach a Staggering US$2.42 Billion Valuation by 2033

The Global Stabilometric Platform Industry is on the cusp of a transformative era, with a projected market value of US$1.19 billion in 2023 expected to skyrocket to a staggering US$2.42 billion by 2033, according to the latest analysis by leading industry experts. This remarkable growth is underlined by a compelling Compound Annual Growth Rate (CAGR) of 7.3%, signalling a paradigm shift in the industry’s trajectory.

The comprehensive market analysis, forecasting, and trends revealed by these eminent analysts shed light on the dynamic forces propelling the Global Stabilometric Platform Industry into uncharted territories. The surge in market value is attributed to a convergence of factors, including technological advancements, a growing awareness of healthcare, and an increasing demand for precise diagnostic tools.

At the heart of this industry’s growth is the Stabilometric Platform, a groundbreaking device designed to measure body movements with utmost precision. Operating in a standing position, the stadiometer – a force-measuring platform – is pivotal to understanding and monitoring the body’s balance. The platform, with its flat and regular surface, is intricately connected to four force transduction systems. Achieving and maintaining the correct balance in the human body necessitates a delicate collaboration of the nerve, musculoskeletal system, and balance organs, all monitored incessantly by the central nervous system.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-5047

High blood pressure has an impact on all aspects of the balance system. The central nervous system regulates the body’s vertical position by slightly shifting the centre of gravity. Using appropriate movement strategies, the correct position of the centre of gravity is obtained. The presence of hypertension impairs the functioning of the control system, resulting in the appearance of the first symptoms of losing control over the body’s balance. A test on a stabilometric platform can be used to detect this symptom.

A force measuring platform is a device similar to a weighing scale that quantifies the centre of pressure using a set of force transducers. The analysis of the centre of pressure is part of the stabilometric platform evaluation. This centre of pressure reflects the motor pattern at the ankle, and the central nervous system responds to correct the body’s centre of mass imbalance. Stabilometric platforms collect information about a person’s postural control and balance. Data obtained from the stabilometric platform has resulted in a few medical advances. However, because the data obtained cannot be analysed directly, some data analysis techniques must be used. Balance control is a sophisticated neuronal mechanism based on both unconditional and conditioned reflexes. Because the mechanism requires the participation of brain regions, posture support mechanism training can be a highly effective tool for rehabilitation.

The stabilometric platform is widely used for training balance skills with visual biofeedback. The stabilometric platform automatically evaluates parameters such as the length of the ideal trajectory, trial type, target point location, speed and length of the real trajectory of the projections of the centre of gravity between the target points. The designations used to indicate the direction of body movements during stabilometric platform measurements are Left (L), Right (R), Anterior (A), and Posterior (P) (P). These guidelines are always defined from the subject’s perspective. The use of a stabilometric platform is a reproducible and objective method for assessing and documenting balance skills. The stabilometric platform allows for the localization of the person’s centre of gravity on the ground projection, the dynamics and localization of the centre of gravity of each foot, load distribution between the left and right foot, and so on. This data can be used to evaluate vestibular, postural, dental, and podiatric dysfunctions, as well as orthopaedic and pathologies.

Initially, the stabilometric platform was only used to assess patient balance and postural control. However, it is now recognised as a valuable tool for treating and diagnosing balance disorders.

Ask Us Your Questions About This Report
https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-5047

Global Stabilometric Platform Industry: Drivers and Restraints

The Global Stabilometric Platform Industry is expanding as people become more aware of the various diagnosis options for balance and postural control disorders. The market for stylometric platforms is being driven by factors such as improved quality of life, functional independence, and increased awareness of balance skills, among others. However, the high cost of equipment and the scarcity of skilled personnel to operate these platforms are likely to stymie market growth.

Global Stabilometric Platform Industry: Overview

Stabilometric platforms are the most accurate equipment in testing balance disorders. Based on the types, the Global Stabilometric Platform Industry is segmented into single function and multi-function. Multi-function stabilometric platform is the most widely used stabilometric platform type across the globe.

Stabilometric Platform Industry: Regional Overview

North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, and the Middle East and Africa are the regions where the Global Stabilometric Platform Industry is divided. North America is expected to dominate the market during the forecast period due to high acceptance of innovative devices and an increase in the geriatric population. The Western European market for stabilometric platforms is expected to be the second largest. The Asia Pacific market is expected to grow steadily due to current low awareness of balance and postural control techniques, as well as low healthcare expenditure.

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-5047

Global Stabilometric Platform Industry: Key Players

Some of the players identified in Global Stabilometric Platform Industry include MEDI-CARE SOLUTIONS srl, Sensing Future Technologies, TECHNO CONCEPT, Vertigomed, WOODWAY, Easytech srl, Biodex, Man&Tel, Framiral, Vestibular Research & Development, LLC. (Balanceback), Techmed, etc.

Global Stabilometric Platform Industry Key Segments

By Types:

Single function
Multi-function

By End User:

Hospitals
Rehabilitation Centers
Nursing Homes

By Regions:

North America
Europe
Asia Pacific
Latin America
MEA

Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the keyword market
Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Explore Wide-ranging Coverage of FMI’s Healthcare Landscape:

The Global Surgical Retractors Market was valued at around US$ 1.8 Billion in 2021. With a projected CAGR of 8% for the next ten years, the market is likely to reach a valuation of nearly US$ 4.1 Billion by the end of 2032.

The Global 3D Printed Prosthetics Market will most likely garner a market value of US$ 1.62 Billion in 2023 and is expected to accumulate a market value of US$ 3.50 Billion by registering a CAGR of 8% in the forecast period 2023 to 2033.

The Global Arterial Cannula Market garnered a market value of US$ 21 Billion in 2023 and is expected to accumulate a market value of US$ 40 Billion by registering a CAGR of 6.6% in the forecast period 2022 to 2033.

Author

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Global Portable Anesthesia Systems Industry Gains Momentum, Targets a 6.6% CAGR, and Aspires to Reach US$ 933.4 Million by 2033

The Global Portable Anesthesia Systems Industry is on track to experience remarkable growth, with a projected compound annual growth rate (CAGR) of 6.6% from 2023 to 2033, according to the latest forecast by Future Market Insights Inc. The market size for portable anesthesia systems is expected to exceed US$ 493.6 million in 2023 and reach an impressive valuation of US$ 933.4 million by 2033.

The growth of the portable anesthesia systems market can be attributed to the advancements in medical technology, which have led to the development of highly effective and compact devices. These cutting-edge systems enable medical professionals to administer anesthesia in a portable and practical manner, transforming patient care.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-5182

Portable anesthesia systems are essential due to an upsurge in surgical operations worldwide. With the flexibility and mobility that these systems provide, medical personnel may provide anesthesia in a variety of situations outside of conventional operating rooms, including ambulatory surgical facilities, dentist offices, and distant sites. The capacity to provide anesthesia in these circumstances broadens the scope of medical care and makes therapy for patients more practical and accessible.

The development of the Global Portable Anesthesia Systems Industry has been greatly aided by the miniaturization trend of medical equipment. Healthcare professionals may provide anesthesia in a variety of clinical settings, including distant or resource-constrained locations, owing to the compact, lightweight, and portable design of these devices. The mobility aspect makes it possible for medical personnel to respond to emergencies or give anesthesia during medical missions or disaster relief activities.

The market for portable anesthetic systems is projected to develop as a result of ongoing technological advancements. For instance, integrating real-time data exchange, wireless connectivity, and enhanced monitoring capabilities can increase patient safety and better anesthetic management. The development of more user-friendly and intuitive interfaces due to technological developments may make portable anesthetic devices more available to healthcare providers.

Asia Pacific is predicted to dominate the global market during the forecast period. In recent years, surgical operations in the region of Asia Pacific has significantly increased. The demand for procedures requiring the administration of anesthesia has increased as a result of the growing frequency of chronic illnesses, lifestyle-related ailments, and age-related problems. Patients from all over the world travel to India, Thailand, and Malaysia, which have also become well-known medical tourism destinations. These factors proliferate market growth in Asia Pacific.

Global Portable Anesthesia Systems Industry Recent Developments Observed by FMI:

By absorbing Penlon Ltd.’s shares from BPL Medical Technology in January 2022, Medcaptain Medical Technology Ltd. (MMTL) acquired Penlon Ltd.
Arab Health 2022 included a live demonstration of Medovate’s state-of-the-art regional anesthetic device SAFIRA in January 2022. Medovate, a producer of medical equipment, collaborated with doctors from the National Health Service (NHS) of the United Kingdom to develop SAFIRA, which is expected to transform regional anesthesia globally.
The next-generation computer-assisted local anesthetic from Ronvig Dental was introduced in May 2021 and is called CALAJECTTM. It was selected ‘2022 Top Award Winner – Anesthetic Device’ by Dental Advisor. The mechanism regulates the flow rate to provide a steady and gentle delivery of anesthetic. Even palatal injections may be administered to patients with minimal discomfort.

Reach Out to Our Analyst For Your Queries
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-5182

Prominent Players in the Global Portable Anesthesia Systems Industry

WandDental
Milestone Scientific
Evident Inc.

Global Portable Anesthesia Systems Industry Segmentation

By Application:

Medical Specialties
Anesthesiology
Orthopedic Surgery
Pain Medicine
Physical Medicine/Rehabilitation
Primary Care/Urgent Care
Rheumatology
Sports Medicine
Dental Specialties
Others

By Surgery Type:

Open Surgery
Minimally Invasive Surgeries

By End Users:

Hospitals
Clinics
Ambulatory Surgical Centers
Others

By Region:

North America
Latin America
Europe
Asia Pacific
The Middle East & Africa (MEA)

Click Here To Buy Your Full Report
https://www.futuremarketinsights.com/checkout/5182

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Global Veterinary Glucometer Industry Set to Achieve Remarkable US$ 574.9 Million by 2033 | Reports FMI

The Global Veterinary Glucometers Industry is poised to transform the animal healthcare landscape with its remarkable growth projection, valued at US$ 351.3 million in 2023 and expected to soar to US$ 574.9 million by 2033, according to a recent report by Future Market Insights Inc. This astounding growth is attributed to the escalating demand for precise and efficient monitoring tools in veterinary care, with a forecasted Compound Annual Growth Rate (CAGR) of 5.0% during the forecast period.

As the need for advanced diagnostic solutions in veterinary medicine intensifies, the Global Veterinary Glucometers Industry is responding with innovative technologies designed to monitor blood glucose levels in animals with unprecedented accuracy. These state-of-the-art devices empower veterinarians to make informed decisions when diagnosing and managing conditions such as diabetes, ultimately improving animal health outcomes.

Emerging trends in the Global Veterinary Glucometer Industry indicate a significant rise in cases of animal diabetes. The efficiency of glucometers, specially tailored for dogs and cats, is expected to drive the demand for veterinary glucometers through 2032. Key players in the industry are responding to this demand by introducing new portable devices, and setting new standards and manufacturing trends for the market.

The expanding veterinary glucometer market size is attributed to its easy-to-use glucose test in practice in the field or at home. It is based on biosensors and auto-code technology. These veterinary glucometers have an additional bell or whistle and can upload readings in an electronic format after performing the test. These are some of the primary factors boosting the demand for veterinary glucometers.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-5367

What are the Major Drivers and Restraints of the Global Veterinary Glucometers Industry?

The global market of veterinary glucometers is expected to be driven by advancements in technology. The market is expected to grow by some factors such as clients expecting a higher level of care and nominally invasive procedures for their pets which propositionally boost the sales of veterinary glucometers.

Based on animal type, it is the major segment of the veterinary glucometer market which includes companion animals such as dogs and cats. The other segment of the Global Veterinary Glucometers Industry is based on end-users which includes veterinary hospitals, veterinary clinics, and home care settings.

Global Veterinary Glucometers Industry is Boosted by Rising Pet Obesity Rates

Obesity is the main risk factor for developing diabetes. The main element influencing the adoption of veterinary glucometers is thought to be the rise in the number of obese dogs. Approximately 35% of pets, according to statistics from the American Veterinary Medical Association, are obese or overweight. Diabetes and liver disease are two conditions that can develop in overweight animals. If untreated, these disorders could be lethal. Therefore, during the projection period, key players are likely to witness a considerable increase in sales of veterinary glucometers due to the rising incidence of obese pet populations that are at a greater risk of getting diabetes.

Additionally, increased awareness of animal health presents a profitable opportunity for the manufacturers in the Global Veterinary Glucometers Industry. In addition, factors like an increase in the prevalence of diabetes in animals and a rise in the demand for livestock products also contribute to the veterinary glucometers market growth. However, the veterinary glucometers market growth is constrained by the absence of veterinary infrastructure facilities in poor countries.

Pet Glucose Monitors are devices used to measure the blood glucose levels of animals. These devices work in a similar way to human glucometers, using a small amount of blood to determine the glucose concentration in the blood.

Reach Out to Our Analyst For Your Queries
https://www.futuremarketinsights.com/ask-question/rep-gb-5367

Regional Analysis

What is the North America Growth Outlook for the Global Veterinary Glucometer Industry?

North America is expected to lead the market with better healthcare facilities and growing advancing technology in the region. North American market holds a significant share in the veterinary glucometers market with 42% of the global market share. The rising demand for veterinary glucometers is mainly rising in the North American region due to the changing lifestyle of pets and animals, especially native lifestyle being the biggest problem.

How is Europe Performing in the Global Veterinary Glucometer Industry?

With a global market share of 33%, the European veterinary glucometers market grows at a steady CAGR for veterinary glucometers. The second largest market is held by Europe market followed by Asia Pacific due to increasing awareness for veterinary diseases. The veterinary glucometers market in this region is anticipated to be one of the fastest growing markets due to a large number of animal populations and rising diseases amongst animals due to inactive lifestyles and poor management.

Recent mergers and product launches

Pro zinc (protamine zinc recombinant human insulin) was introduced by Boehringer Ingelheim International GmbH in August 2020 as a daily single-dose medication for dogs with diabetes.
In August 2019, Zoetis said that partner firms Merck Animal Health and Purina continue to support its Diabetes Pet Care Alliance initiative.
Nova Biomedical introduced Ketone/Glucose Meter known as Nova Vet under its Nova biomedical section that measures blood beta-hydroxybutyrate (BHB) that gives the results in just 10 seconds. These fuels the sales of veterinary glucometers.
TaiDoc Technology Corporation has added new modern vet glucose monitoring machines that have a reaction time of 5 seconds with a memory of 400 sets. These fuels the sales of veterinary glucometers.

Click Here To Buy Your Full Report
https://www.futuremarketinsights.com/checkout/5367

Global Veterinary Glucometers Industry Key players

Nova Biomedical
TaiDoc Technology Corporation
BioNote Inc
Woodley Equipment Company Ltd
i-SENS. Inc.
MED TRUST
UltiMed, Inc.
Biotest Medical Corp

Global Veterinary Glucometer Industry Key segments

By Animal Type:

Dogs
Cats

By End User:

Veterinary Hospitals
Veterinary Clinics
Homecare Settings

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Global SPECT Scanning Services Industry Forecasts 7.8% CAGR, Envisioning US$ 4,434.8 Million by 2032 | FMI

The Global SPECT Scanning Services Industry is on the cusp of a phenomenal growth spurt, buoyed by groundbreaking advancements in radiopharmaceuticals. According to a recent study, the industry, which stood at a respectable US$ 1,950.6 Million in 2022, is poised to exhibit a remarkable Compound Annual Growth Rate (CAGR) of 7.8%, catapulting it to an impressive US$ 4,434.8 Million valuation by 2032.

This exceptional growth trajectory can be attributed to several factors, most notably, the pioneering work in radiopharmaceuticals. Researchers and developers have been relentless in their pursuit of creating cutting-edge diagnostic solutions, resulting in novel applications of SPECT scanning technology. Consequently, the industry is witnessing increased adoption in various medical specialties, including cardiology, oncology, and neurology, among others.

The global healthcare landscape is witnessing a surge in the prevalence of various health challenges, particularly an alarming increase in cancer cases, coupled with a rising incidence of brain diseases, heart difficulties, and bone disorders. In response to this critical demand for advanced diagnostic tools, SPECT scanning services are emerging as a crucial component of modern medical diagnostics.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-4122

The SPECT scanners consist of radioactive substances and a high-resolution camera to form 3D pictures. These devices are safe to use. The procedure involving the SPECT scanner is simple. A radioactive tracer is injected into the blood, which produces gamma rays. The camera captures the image, and this image is presented on the computer. The affected area will appear dark in color. Less tracker would mean the cell in the particular area is dead.

Top Drivers Influencing the Global SPECT Scanning Services Industry
Increasing Investment in Research and Development:

With increasing cases of certain health complications like cancer, brain disorders, heart problems, and bone disorders, the medical community is investing heavily in research and development.

To analyze the condition of certain body parts during R&D, more and more usage of SPECT scanners is expected. This might increase the demand for SPECT scanning services.

Wide Range of Applications:

One of the biggest advantages of using SPECT scanners is the wide range of applications they provide. The application further increases if they are used along with MRI and CT scans for better imaging quality and high-resolution images.

Reach Out to Our Analyst For Your Queries
https://www.futuremarketinsights.com/ask-question/rep-gb-4122

Accuracy:

The SPECT scanners are known to work with a high level of accuracy. The SPEC scanners operate based on nuclear medicine imaging techniques.

The ability of nuclear imaging techniques to accurately detect molecular activity in the body and diagnose diseases at their earliest stages is expected to increase the demand for SPECT scanning services.

Opportunities Ahead for the Global SPECT Scanning Services Industry

Opportunities:

Data Integrating Imaging Systems:

By using data-integrated imaging systems, it is possible to process and reconstruct images, identify medical conditions through computer-assisted recognition, create 3D images, and employ quality control measures.

Data integration makes it easier for doctors to compare scans and track the disease’s progression. This is expected to change the outlook of Global SPECT Scanning Services Industry

Competitive Landscapes:

What are the Major Players in the Global SPECT Scanning Services Industry?

The global demand for SPECT scanning services is highly fragmented and competitive due to the presence of numerous regional and local companies. Major players use a variety of marketing strategies, including mergers and acquisitions, developments, alliances, and partnerships.

Increasing a company’s share of the consumer market also entails developing new products. As a result of these advancements, the effectiveness of SPECT scanning services has increased.

Some of the key players are Gamma Medica Inc., GE Healthcare, Siemens Healthineers, Toshiba Medical Systems Corporation, Mediso Medical Imaging Systems Ltd., Digirad Corporation, Positron Corporation, DDD Diagnostics, Cubresa Inc., and others.

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-4122

Key segments

By Design:

Encapsulated
Linear resonant actuators
PCB mounted
brushless coin
Brushed coin
Eccentric rotating mass

By Product Type:

Eccentric rotating mass vibration motor (ERM)
DC motor

By Application:

Medical
Commercial
Cruise shipbuilding and ship repair

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Global Air Fluidized Therapy Beds Industry to See a Substantial Growth, worth US$ 1,135 Million by 2033, with a CAGR of 5.7% | FMI

The Global Air Fluidized Therapy Beds Industry is projected to experience a remarkable growth trajectory, with a compound annual growth rate (CAGR) of 5.7% between 2023 and 2033, according to the latest report published by Future Market Insights (FMI). The market is expected to reach a staggering valuation of US$ 1,135 million by 2033, up from its current value of around US$ 700 million.

Air fluidized therapy beds, also known as low-air-loss mattresses or alternating pressure mattresses, are designed to provide optimal support and pressure relief to patients, especially those who are immobile or bedridden for extended periods. The growing demand for these beds can be attributed to several factors, including the increasing prevalence of chronic conditions such as obesity, diabetes, and cardiovascular diseases, which require prolonged bed rest. Additionally, the rising geriatric population and the growing awareness about the benefits of air-fluidized therapy beds are also expected to drive the market’s growth.

The demand for these beds is on the rise worldwide, driven by technological innovations and advancements in medical treatments. Hospitals are increasingly adopting air-fluidized therapy beds to cater to the evolving needs of patients and provide cutting-edge healthcare solutions. The beds are not only crucial for burn patients but are also gaining prominence in addressing skin-related conditions.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-5035

Global Air Fluidized Therapy Beds Industry Key Takeaways

By 2033, the air fluidized therapy bed market in the United Kingdom is likely to expand, with a CAGR of 4.7%.
In 2022, the United States developed the air fluidized therapy bed business with a share of 36%.
The air fluidized therapy bed market grew considerably to US$ 635.3 million in 2022.
The air-fluidized therapy bed sector expanded at a CAGR of 4.1% from 2018 to 2022.
By 2033, China’s air-fluidized therapy bed market is projected to develop with a CAGR of 7%.
By 2033, India’s air-fluidized therapy bed industry is projected to expand with a CAGR of 5.7%.
Japan’s air fluidized therapy bed industry grew significantly, with a 3.8% share in 2022.
Australia’s air-fluidized therapy bed is likely to expand with a CAGR of 5.1% by 2033.
Germany’s air fluidized therapy bed business grew, with a share of 8.2% in 2022.
In 2022, based on the indication, pressure ulcers dominated the market, with a share of 57.3%.
In 2022, the hospitals segment dominated the market, with a share of 62.1%, based on end-user

Click Here to Request Methodology!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-5035

Global Air Fluidized Therapy Beds Industry Competitors Winning Strategies

Local and regional manufacturers serve certain geographic areas through regionalized customer assistance, affordable solutions, and in-depth knowledge of regional healthcare practices and laws.

Gaining the faith and confidence of healthcare institutions, experts, and end users is imperative for market players, and compliance with regulatory requirements and certifications is key to this.

To guarantee the best possible use of air-fluidized treatment beds, businesses offer outstanding customer service, prompt maintenance assistance, and thorough training programs for healthcare professionals.

Baxter became the top Medtech company in the world in December 2021 when it acquired Hill-Rom for US$ 15 billion. As a result, Baxter improved its technology, giving patients greater treatment in hospitals and at home. Moreover, Baxter anticipates a significant ROIC from this purchase.

Global Air Fluidized Therapy Beds Industry Key players

Hill-Rom,
Dolphin System
AURORA MFG,
American Medical Equipment
Blue Chip Medical
Akthel Healthcare BV
ArjoHuntleigh

Click Here To Buy Your Full Report
https://www.futuremarketinsights.com/checkout/5035

Global Air Fluidized Therapy Beds Industry Key Segments

By Indication:

Pressure Ulcers
Burns
Other Indications

By End User:

Hospitals
Ambulatory Surgical Centers
Other End Users

By Region:

North America
Latin America
Europe
East Asia
South Asia & Pacific
Middle East & Africa

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Global Staphylococcus Aureus Testing Industry Set for Rapid Expansion: Market Forecasted to Reach US$6.9 Billion by 2033, Driven by Increasing Healthcare Demands

The Global Staphylococcus Aureus Testing Industry is set to experience rapid growth in the coming years, with a projected valuation of US$6.9 billion by 2033, according to a new report by Future Market Insights (FMI). The market is expected to register a compound annual growth rate (CAGR) of 5.3% between 2023 and 2033, starting from a valuation of $4.1 billion in 2023.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-5284

Growing Advanced Technologies and Awareness Fuel the Global Staphylococcus Aureus Testing Industry

Several Factors Driving the Global Market Significantly to Acquire Huge Revenue. These are as follows:

Increasing Prevalence of Staphylococcus Aureus Infections: The rising bacterial diseases such as Staphylococcus aureus include bloodstream infections, pneumonia, skin infections, and surgical site infections. The growing number of these infections worldwide is increasing the adoption of staphylococcus aureus testing.
Rising Awareness and Concerns: Healthcare professionals and patients have growing awareness towards Staphylococcus aureus strains, including MRSA (Methicillin-resistant Staphylococcus Aureus). It helps to manage and identify antibiotic-resistant strains.
Increasing Healthcare-Associated Infections: The rising incidence of Healthcare-Associated Infections and increasing the demand for staphylococcus aureus testing for effective testing. It helps to prevent and control these diseases speedily in healthcare settings.
Advanced Diagnostic Technologies: The growing advanced technologies, such as nucleic acid amplification tests and immunoassays, are increasing the demand for staphylococcus aureus testing for accurate and reliable testing. Healthcare professionals who focus on treating patients are driving the global market.
Increasing Demand for Point-of-Care Testing: The growing patient treatment, rapid diagnosis, and immediate treatment decisions are increasing the adoption of point-of-care testing. It is widely adopted in various healthcare settings such as clinics, hospitals, emergency departments, and ambulatory care.
Growing Investments in Research and Development Activities: The huge rising investment in research and development activities to introduce new testing tactics driving the global market growth.

These factors are collectively upsurging the Global Staphylococcus Aureus Testing Industry during the forecast period.

Key Takeaways:

The Staphylococcus aureus testing market is estimated to capture a valuation of US$ 6.9 billion with a CAGR of 5.3% by 2033.
In the historical period, the market secured a valuation of US$ 3.9 billion with a CAGR of 6.7% in 2022
North America is significantly driving the global market by capturing a share of 48.7% in the global market by 2033.
Europe is estimated to register a share of 33.4% in the global market during the forecast period.
The hospital sector is securing a maximum global market share by 2033.

Click Here to Request Methodology!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-5284

How Key Players Are Adopting Strategic Innovations in the Global Staphylococcus Aureus Testing Industry?

The market is highly competitive by the prominent players that heavily invest in research and development activities. These players play a key role in developing improved, advanced, and innovative products globally. They focus on consumers’ requirements and offer them high-quality, customized products.

These players are adopting various marketing strategies to drive the global market to another level. These marketing tactics are mergers, acquisitions, collaborations, partnerships, agreements, and product launches. Key players promote their brands on several platforms, such as online retailers, seminars, exhibitions, trade shows, and online marketing.

Recent Developments in the Global Staphylococcus Aureus Testing Industry are:

Roche Diagnostics announced its newly launched product molecular diagnostic solution for Staphylococcus aureus testing. The company offers customized molecular diagnostic solutions with its specialized team to enhance its business portfolio.

Global Staphylococcus Aureus Testing Industry Key Companies Profiled

Abbott Laboratories Inc
Siemens Healthcare GmbH
Bio Rad Laboratories Inc
Thermo Fisher Scientific Inc
Roche Diagnostics (H. Hoffman-La Roche Ltd.)
STD Rapid Test Kits

Click Here To Buy Your Full Report
https://www.futuremarketinsights.com/checkout/5284

Global Staphylococcus Aureus Testing Industry by Category

By Test Type:

Coagulase Test
Ancillary Tests
Agar-Based Tests
Nucleic Acid Amplification Tests

By Application:

Pharmaceutical
Clinical
Food Testing
Other

By End User:

Hospitals
Diagnostic Clinics
Food Testing laboratories
Others

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East and Africa

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Global Hemostasis Products Industry Sees Promising Future: Forecasted to Reach US$2.65 Billion by 2033 with a 5.3% CAGR | FMI

The Global Hemostasis Products Industry is on track for substantial expansion, with a projected valuation of US$1.58 billion in 2023 and expected growth beyond US$2.65 billion by 2033, according to a recent report by Future Market Insights (FMI). This impressive growth trajectory is anticipated to unfold at a steady Compound Annual Growth Rate (CAGR) of 5.3% during the forecast period.

High-level technological advancements, strong economies, and a swarming pool of patients with a variety of blood disorders are the chief factors that will boost the market for hemostasis products shortly. The leading causes of surgeries are cardiovascular disease and stroke, cancer, and injury. And any surgical procedure can develop severe complications and result in uncontrollable bleeding thus increasing the demand for hemostasis products.

The rapidly growing medical tourism sector coupled with the high investment made by governments of various countries towards the growth of the healthcare sector will provide lucrative opportunities for the growth of the market. The high expenses related to hemostasis products and stringent regulatory policies and the use of off-label products are projected to restrain the market’s growth over the forecast period.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-15386

The topical hemostasis product segment is likely to offer remunerative opportunities for the Global Hemostasis Products Industry. Several emerging economies are making significant developments in their technological sector, thereby, providing lucrative opportunities to players in the market.

Global Hemostasis Products Industry Key Takeaways:

The Global Hemostasis Products Industry is estimated at USD 1,501 Million in 2021
By product, the topical hemostat segment accounts for a market share of 68.5% in 2021
By application, the myocardial infarction segment accounts for the highest market share of 19.5% during the forecasting period.
Market in the U.S to procure a market share of 29.5% during the assessment period.

“The increasing number of trauma and surgical cases, technological advancements in the fields of hemostasis products, and an increase in the prevalence of blood disorders are expected to fuel the demand for Global Hemostasis Products Industry over the forecast period” says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)

Have a Conversation with the Analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-15386

Competitive Landscape

Medtronic
Johnson & Johnson
Baxter International
Pfizer Inc.
Becton Dickinson and Company (BD)
B. Braun Melsungen AG
Tricol Biomedical
Hemostasis LL
Teleflex Incorporated
CuraMedical BV

Recent updates from the industry are:

In July 2021- Baxter International Inc announced its Baxter Healthcare Corporation subsidiary has completed the acquisition of certain assets related to PerClotPolysaccharide Hemostatic System from CryoLife, Inc. The transaction reinforces Baxter’s strategy of acquiring products and technologies that both complement and augment the company’s leading portfolio across the hospital, including in the operating room. PerClot has a global commercial presence with sales in more than 35 countries worldwide.
Hemostasis is committed to producing high quality medical devices that are safe and effective for their intended use. Hemostasis introduced. BoneSeal bone hemostat is a new generation, absorbable solution providing immediate and long-term hemostasis without immediately dissolving. BoneSeal hemostat works quickly and delivers better results for you and your patients.

To Buy this Report Visit
https://www.futuremarketinsights.com/checkout/15386

Key Segments Covered in the Hemostasis Products Industry Analysis

Global Hemostasis Products Industry by Product:

Topical Hemostasis Products
- Gelatin
- Polysaccharides
- Oxidized Regenerated Cellulose
- Collagen
Infusible Hemostasis Products
- Platelet Concentrate from Donor Blood
- Fresh Frozen Plasma (FFP)
- Factor VIII
- Prothrombin
Advanced Hemostasis Products
- Flowable
- Thrombin
- Synthetic Sealants
- Fibrin

Global Hemostasis Products Industry by Application:

Hemostasis Products for Trauma
Hemostasis Products for Surgery
Hemostasis Products for Hemophilia
Hemostasis Products for Myocardial Infarction
Hemostasis Products for Others

Global Hemostasis Products Industry by End Use:

Hemostasis Products in Hospitals
Hemostasis Products in Ambulatory Surgical Centers
Hemostasis Products in Others

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani